Synthetic DNA provides a safer blood clot treatment
New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects.
aptamer
Nanopores for precision diagnostics
Researchers developed a nanopore platform that detects a range of biomarkers at the same time, paving the way for more precise liquid biopsies.
